Clinical Trials | May 02, 2023
Lilly's Lebrikizumab shows improved face or hand dermatitis
Lebrikizumab is an investigational high-affinity and potent IL-13 inhibitor being studied in adult and adolescent patients
Lebrikizumab is an investigational high-affinity and potent IL-13 inhibitor being studied in adult and adolescent patients
The company has posted net profit of Rs.464.4 crores for the Financial Year ended March 31, 2023
He mentioned that Thyroid disorders are a common health problem in Jammu and Kashmir
Government hospitals like AIIMS, KGMC & many more as per day OPD patients are 18-25 thousand
New York State’s largest health system adopts Philips patient monitoring platform to drive integration and innovation for a better patient and staff experience and improved outcomes
PM to launch TB-Mukt Panchayat initiative; official pan-India rollout of a shorter TB Preventive Treatment and Family-centric care model for TB
Integration of modern and traditional medicine to facilitate the illness to wellness journey
This is especially the case if the patients are young, have multiple blocks & have conditions that may make angioplasty to implant drug-eluting stents ineffective
New Building at Rockford, Illinois site will significantly increase equipment and capacity for injectable biologics and other self-administered therapies
This new capability represents a significant shift from a microscope-based standard of care to the use of digital whole slide images
Subscribe To Our Newsletter & Stay Updated
